These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34526412)

  • 41. Urinary Liver Type Fatty Acid Binding Protein Is Negatively Associated With Estimated Glomerular Filtration Rate in Renal Transplant Recipients With Graft Loss.
    Huang YC; Chang YS; Chen CC; Tsai SF; Yu TM; Wu MJ; Chen CH
    Transplant Proc; 2018 May; 50(4):1083-1086. PubMed ID: 29731071
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protective effects of tubular liver-type fatty acid-binding protein against glomerular damage in murine IgA nephropathy.
    Zuo N; Suzuki Y; Sugaya T; Osaki K; Kanaguchi Y; Wang L; Tomino Y
    Nephrol Dial Transplant; 2011 Jul; 26(7):2127-37. PubMed ID: 21109611
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased Urinary Liver-Type Fatty Acid-Binding Protein Level Predicts Major Adverse Cardiovascular Events in Patients With Hypertension.
    Okubo Y; Nakano Y; Tokuyama T; Hironobe N; Okamura S; Ikeuchi Y; Miyauchi S; Kihara Y
    Am J Hypertens; 2020 Jul; 33(7):604-609. PubMed ID: 32155236
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship between Urinary Liver-Type Fatty Acid-Binding Protein (L-FABP) and Sarcopenia in Spontaneously Diabetic Torii Fatty Rats.
    Tanabe J; Ogura Y; Kosaki K; Nagai Y; Sugaya T; Ohata K; Watanabe S; Ichikawa D; Inoue K; Hoshino S; Kimura K; Maeda S; Shibagaki Y; Kamijo-Ikemori A
    J Diabetes Res; 2020; 2020():7614035. PubMed ID: 32405506
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relationship between exercise capacity and urinary liver-type fatty acid-binding protein in middle-aged and older individuals.
    Kosaki K; Kamijo-Ikemori A; Sugaya T; Tanahashi K; Kumagai H; Sawano Y; Akazawa N; Ra SG; Kimura K; Shibagaki Y; Maeda S
    Clin Exp Nephrol; 2017 Oct; 21(5):810-817. PubMed ID: 28197733
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Possibility of Urinary Liver-Type Fatty Acid-Binding Protein as a Biomarker of Renal Hypoxia in Spontaneously Diabetic Torii Fatty Rats.
    Tanabe J; Ogura Y; Nakabayashi M; Nagai Y; Watanabe S; Sugaya T; Ohata K; Ichikawa D; Inoue K; Hoshino S; Kimura K; Shibagaki Y; Ono Y; Kamijo-Ikemori A
    Kidney Blood Press Res; 2019; 44(6):1476-1492. PubMed ID: 31734667
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of erythropoietin on urinary liver-type fatty-acid-binding protein in patients with chronic renal failure and anemia.
    Nakamura T; Sugaya T; Kawagoe Y; Suzuki T; Ueda Y; Koide H
    Am J Nephrol; 2006; 26(3):276-80. PubMed ID: 16772708
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Value of urinary liver fatty acid-binding protein in assessing severity of brain trauma and predicting acute kidney injury].
    Wu GY; Zhuang K; Liu Y; Wang ZF
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Nov; 36(11):1527-1530. PubMed ID: 27881344
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mass spectrometric quantification of urinary human liver fatty acid binding protein in renal transplant recipients.
    Ozcan F; Akbas H; Kırac E; Suleymanlar G; Aslan M; Yucel G
    Rapid Commun Mass Spectrom; 2016 Mar; 30(5):603-10. PubMed ID: 27043149
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Urinary liver-type fatty acid-binding protein level as a predictive biomarker of contrast-induced acute kidney injury.
    Manabe K; Kamihata H; Motohiro M; Senoo T; Yoshida S; Iwasaka T
    Eur J Clin Invest; 2012 May; 42(5):557-63. PubMed ID: 22070248
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Liver-type fatty acid-binding protein and neutrophil gelatinase-associated lipocalin in cats with chronic kidney disease and hyperthyroidism.
    Kongtasai T; Meyer E; Paepe D; Marynissen S; Smets P; Mortier F; Demeyere K; Vandermeulen E; Stock E; Buresova E; Defauw P; Duchateau L; Daminet S
    J Vet Intern Med; 2021 May; 35(3):1376-1388. PubMed ID: 33723886
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Urinary excretion of liver fatty acid-binding protein in health-check participants.
    Ishimitsu T; Ohta S; Saito M; Teranishi M; Inada H; Yoshii M; Minami J; Ono H; Hikawa A; Shibata N; Sugaya T; Kamijo A; Kimura K; Ohrui M; Matsuoka H
    Clin Exp Nephrol; 2005 Mar; 9(1):34-9. PubMed ID: 15830271
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of snake envenomation-induced renal dysfunction in dogs using early urinary biomarkers of nephrotoxicity.
    Hrovat A; Schoeman JP; de Laat B; Meyer E; Smets P; Goddard A; Nagel S; Daminet S
    Vet J; 2013 Oct; 198(1):239-44. PubMed ID: 23916665
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Significance of urinary liver-type fatty acid-binding protein in patients with normal renal function after undergoing intestinal urinary diversion: a preliminary study.
    Maehana T; Ichihara K; Takahashi S; Takahashi Y; Hashimoto K; Tanaka T; Masumori N
    Clin Exp Nephrol; 2021 Oct; 25(10):1151-1157. PubMed ID: 34100166
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Utility of urinary tubular markers for monitoring chronic tubulointerstitial injury after ischemia-reperfusion.
    Ichikawa D; Kamijo-Ikemori A; Sugaya T; Ohata K; Hisamichi M; Hoshino S; Kimura K; Shibagaki Y
    Nephrology (Carlton); 2018 Apr; 23(4):308-316. PubMed ID: 28063188
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Monitoring of urinary L-type fatty acid-binding protein predicts histological severity of acute kidney injury.
    Negishi K; Noiri E; Doi K; Maeda-Mamiya R; Sugaya T; Portilla D; Fujita T
    Am J Pathol; 2009 Apr; 174(4):1154-9. PubMed ID: 19264903
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Urinary liver-type fatty acid binding protein is an independent predictor of stroke and mortality in individuals with type 1 diabetes.
    Panduru NM; Forsblom C; Saraheimo M; Thorn LM; Gordin D; Elonen N; Harjusalo V; Bierhaus A; Humpert PM; Groop PH;
    Diabetologia; 2017 Sep; 60(9):1782-1790. PubMed ID: 28601908
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Urinary markers in the early stage of nephropathy in patients with childhood-onset type 1 diabetes.
    Suh JS; Kim SH; Cho KS; Jung IA; Cho WK; Jeon YJ; Jung MH; Suh BK
    Pediatr Nephrol; 2016 Apr; 31(4):623-31. PubMed ID: 26525196
    [TBL] [Abstract][Full Text] [Related]  

  • 59. L-type fatty acid binding protein transgenic mouse as a novel tool to explore cytotoxicity to renal proximal tubules.
    Nakamura K; Ito K; Kato Y; Sugaya T; Kubo Y; Tsuji A
    Drug Metab Pharmacokinet; 2008; 23(4):271-8. PubMed ID: 18762714
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preliminary study of urinary excretion of liver-type fatty acid-binding protein in a cat model of chronic kidney disease.
    Watanabe A; Ohata K; Oikawa T; Sugaya T; Miyazaki M; Satoh H; Katayama M
    Can J Vet Res; 2021 Apr; 85(2):156-160. PubMed ID: 33883825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.